09:28 AM EDT, 08/07/2024 (MT Newswires) -- Enovis ( ENOV ) reported Q2 adjusted earnings Wednesday of $0.62 per diluted share, up from $0.61 a year earlier.

Analysts polled by Capital IQ expected $0.59.

Net sales for the quarter ended June 28 was $525.2 million, compared with $428.5 million a year earlier.

Analysts surveyed by Capital IQ expected $526 million.

The medical technology firm said it now expects 2024 adjusted earnings of $2.62 to $2.77 per diluted share, compared with its prior guidance of $2.52 to $2.67. Analysts polled by Capital IQ expect $2.62.

The company said it narrowed its revenue forecast for the year to between $2.08 billion and $2.13 billion from a prior range of $2.06 billion to $2.16 billion. Analysts surveyed by Capital IQ expect $2.12 billion.